GlassScriptPhysician profile
Thomas Takayama
NPI 1720166184
$3,417.59
in general payments reported to CMS, 2019-2025
35 companies · $1,368 in 2025
The $1,368 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $444 · 2020: $271 · 2021: $332 · 2022: $486 · 2024: $517 · 2025: $1,368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,850 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,850.23 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $578.88 | 2024-2025 | Gemtesa |
| Astellas Pharma US INC | $354.00 | 2019-2022 | |
| Antares Pharma, INC. | $316.41 | 2019-2025 | Xyosted |
| Janssen Biotech, INC. | $232.44 | 2020-2025 | Erleada |
| 180 Medical, INC. | $225.68 | 2019-2024 | Gentlecath |
| Boston Scientific Corporation | $164.45 | 2019-2025 | Ams 800 Artificial Urinary Sphincter |
| Myriad Genetic Laboratories, INC. | $146.15 | 2020-2024 | Prolaris |
| Ferring Pharmaceuticals INC. | $137.00 | 2024-2025 | Adstiladrin |
| Dornier Medtech America, INC | $124.40 | 2025 | Dornier Medtech |
| Urogen Pharma, INC. | $103.73 | 2022-2025 | |
| Coloplast Corp | $103.59 | 2019-2025 | |
| Abbvie INC. | $92.57 | 2024 | |
| Therapeuticsmd, INC. | $84.31 | 2019-2020 | |
| Endo USA, INC. | $83.80 | 2025 | Xiaflex |
| Convatec INC. | $79.22 | 2019-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $67.36 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $61.99 | 2019-2025 | |
| Progenics Pharmaceuticals, INC. | $55.82 | 2024 | |
| Immunitybio, INC. | $53.99 | 2025 | |
| Urovant Sciences INC | $49.49 | 2022 | |
| Baxter Healthcare | $35.93 | 2024-2025 | Tisseel |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Ambu INC. | $28.93 | 2025 | |
| Zyla Life Sciences, INC. | $24.37 | 2020 | |
| Laborie Medical Technologies Corp. | $22.87 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Abbott Laboratories | $18.85 | 2019 | |
| Profound Medical Corp. | $17.82 | 2022 | |
| Smith+Nephew, INC. | $16.57 | 2022 | |
| Pfizer INC. | $16.33 | 2019 | |
| Becton, Dickinson and Company | $15.65 | 2025 | Aptra |
| Medtronic USA, INC. | $14.92 | 2020 | |
| Abc Home Medical Supply, INC. | $14.42 | 2024 | |
| Amag Pharmaceuticals, INC. | $14.40 | 2019 | |
| Endo Pharmaceuticals INC. | $14.04 | 2021 | |
| Rochester Medical Corporation | $12.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Takayama listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.